21903-52-6 Usage
Uses
Used in Sunscreen Industry:
Methyl 4-(2-hydroxyethoxy)-3-methoxybenzoate is used as a UV filter in sunscreens for its ability to absorb and reflect UVB radiation, thereby protecting the skin from sunburn and reducing the risk of skin cancer. Its light and non-greasy texture enhances the user experience, making it a preferred ingredient in sunscreen formulations.
Used in Cosmetic Industry:
In the cosmetic industry, methyl 4-(2-hydroxyethoxy)-3-methoxybenzoate is used as an ingredient in various skincare products to provide UV protection. Its incorporation into these products helps to shield the skin from the damaging effects of the sun while maintaining a pleasant texture and feel on the skin.
It is important to consider the potential for skin irritation and allergic reactions when using products containing methyl 4-(2-hydroxyethoxy)-3-methoxybenzoate, and individuals with sensitive skin may need to exercise caution or opt for alternative ingredients for sun protection.
Check Digit Verification of cas no
The CAS Registry Mumber 21903-52-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,9,0 and 3 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 21903-52:
(7*2)+(6*1)+(5*9)+(4*0)+(3*3)+(2*5)+(1*2)=86
86 % 10 = 6
So 21903-52-6 is a valid CAS Registry Number.
21903-52-6Relevant academic research and scientific papers
COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS
-
Paragraph 0585, (2014/03/25)
Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).
Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part I: Discovery of 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide
Uto, Yoshikazu,Ogata, Tsuneaki,Harada, Jun,Kiyotsuka, Yohei,Ueno, Yuko,Miyazawa, Yuriko,Kurata, Hitoshi,Deguchi, Tsuneo,Watanabe, Nobuaki,Takagi, Toshiyuki,Wakimoto, Satoko,Okuyama, Ryo,Abe, Manabu,Kurikawa, Nobuya,Kawamura, Sayako,Yamato, Michiko,Osumi, Jun
scheme or table, p. 4151 - 4158 (2010/04/29)
A series of structurally novel stearoyl-CoA desaturase-1 (SCD-1) inhibitors has been identified by optimizing a hit from our corporate library. Preliminary structure-activity relationship (SAR) studies led to the discovery of the highly potent and orally bioavailable thiazole-based SCD-1 inhibitor, 3-(2-hydroxyethoxy)-4-methoxy-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide (23a).